Indication
Treatment of endogenous Cushing’s syndrome in adults.
Medicine details
- Medicine name:
- osilodrostat (Isturisa)
- SMC ID:
- SMC2954
- Pharmaceutical company
- Recordati Pharmaceuticals
- BNF chapter
- Endocrine system
- Submission type
- Full
- Publication due date:
- TBC
- SMC meeting date:
- TBC
- Patient group submission deadline:
- TBC